Neurocognitive dysfunction and brain FDG-PET/CT findings in HIV-infected hemophilia patients and HIV-infected non-hemophilia patients.

This single-institution cross-sectional study aimed to grasp the prevalence and features of neurocognitive dysfunction in HIV-infected hemophilia patients in Japan. We conducted neuropsychological tests and medical examinations in 56 HIV-infected hemophilia patients who received outpatient treatment...

Full description

Bibliographic Details
Main Authors: Koubun Imai, Sota Kimura, Yoko Kiryu, Aki Watanabe, Ei Kinai, Shinichi Oka, Yoshimi Kikuchi, Satoshi Kimura, Mikiko Ogata, Misao Takano, Ryogo Minamimoto, Masatoshi Hotta, Kota Yokoyama, Tomoyuki Noguchi, Kensuke Komatsu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0230292
_version_ 1818833556659503104
author Koubun Imai
Sota Kimura
Yoko Kiryu
Aki Watanabe
Ei Kinai
Shinichi Oka
Yoshimi Kikuchi
Satoshi Kimura
Mikiko Ogata
Misao Takano
Ryogo Minamimoto
Masatoshi Hotta
Kota Yokoyama
Tomoyuki Noguchi
Kensuke Komatsu
author_facet Koubun Imai
Sota Kimura
Yoko Kiryu
Aki Watanabe
Ei Kinai
Shinichi Oka
Yoshimi Kikuchi
Satoshi Kimura
Mikiko Ogata
Misao Takano
Ryogo Minamimoto
Masatoshi Hotta
Kota Yokoyama
Tomoyuki Noguchi
Kensuke Komatsu
author_sort Koubun Imai
collection DOAJ
description This single-institution cross-sectional study aimed to grasp the prevalence and features of neurocognitive dysfunction in HIV-infected hemophilia patients in Japan. We conducted neuropsychological tests and medical examinations in 56 HIV-infected hemophilia patients who received outpatient treatment at the AIDS Clinical Center, National Center for Global Health and Medicine. A total of 388 HIV-infected non-hemophilia patients who received outpatient treatment at the same institution were included as a control group. To investigate sites responsible for neurocognitive dysfunction in HIV-infected hemophilia patients using brain FDG-PET/CT scans, the accumulation of FDG in each brain region was compared. Approximately 50% of HIV-infected hemophilia patients had neurocognitive dysfunction. The prevalence of asymptomatic neurocognitive impairment was high (34%). Neurocognitive dysfunction was associated with educational level in HIV-infected hemophilia patients. In the symptomatic group, hemophilic arthropathy and history of cerebrovascular disorders were associated with neurocognitive dysfunction. Left temporal lobe function was reduced in the symptomatic group.
first_indexed 2024-12-19T02:20:48Z
format Article
id doaj.art-d941c5dd5e8343cca15bf668ff0bf701
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-19T02:20:48Z
publishDate 2020-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-d941c5dd5e8343cca15bf668ff0bf7012022-12-21T20:40:14ZengPublic Library of Science (PLoS)PLoS ONE1932-62032020-01-01153e023029210.1371/journal.pone.0230292Neurocognitive dysfunction and brain FDG-PET/CT findings in HIV-infected hemophilia patients and HIV-infected non-hemophilia patients.Koubun ImaiSota KimuraYoko KiryuAki WatanabeEi KinaiShinichi OkaYoshimi KikuchiSatoshi KimuraMikiko OgataMisao TakanoRyogo MinamimotoMasatoshi HottaKota YokoyamaTomoyuki NoguchiKensuke KomatsuThis single-institution cross-sectional study aimed to grasp the prevalence and features of neurocognitive dysfunction in HIV-infected hemophilia patients in Japan. We conducted neuropsychological tests and medical examinations in 56 HIV-infected hemophilia patients who received outpatient treatment at the AIDS Clinical Center, National Center for Global Health and Medicine. A total of 388 HIV-infected non-hemophilia patients who received outpatient treatment at the same institution were included as a control group. To investigate sites responsible for neurocognitive dysfunction in HIV-infected hemophilia patients using brain FDG-PET/CT scans, the accumulation of FDG in each brain region was compared. Approximately 50% of HIV-infected hemophilia patients had neurocognitive dysfunction. The prevalence of asymptomatic neurocognitive impairment was high (34%). Neurocognitive dysfunction was associated with educational level in HIV-infected hemophilia patients. In the symptomatic group, hemophilic arthropathy and history of cerebrovascular disorders were associated with neurocognitive dysfunction. Left temporal lobe function was reduced in the symptomatic group.https://doi.org/10.1371/journal.pone.0230292
spellingShingle Koubun Imai
Sota Kimura
Yoko Kiryu
Aki Watanabe
Ei Kinai
Shinichi Oka
Yoshimi Kikuchi
Satoshi Kimura
Mikiko Ogata
Misao Takano
Ryogo Minamimoto
Masatoshi Hotta
Kota Yokoyama
Tomoyuki Noguchi
Kensuke Komatsu
Neurocognitive dysfunction and brain FDG-PET/CT findings in HIV-infected hemophilia patients and HIV-infected non-hemophilia patients.
PLoS ONE
title Neurocognitive dysfunction and brain FDG-PET/CT findings in HIV-infected hemophilia patients and HIV-infected non-hemophilia patients.
title_full Neurocognitive dysfunction and brain FDG-PET/CT findings in HIV-infected hemophilia patients and HIV-infected non-hemophilia patients.
title_fullStr Neurocognitive dysfunction and brain FDG-PET/CT findings in HIV-infected hemophilia patients and HIV-infected non-hemophilia patients.
title_full_unstemmed Neurocognitive dysfunction and brain FDG-PET/CT findings in HIV-infected hemophilia patients and HIV-infected non-hemophilia patients.
title_short Neurocognitive dysfunction and brain FDG-PET/CT findings in HIV-infected hemophilia patients and HIV-infected non-hemophilia patients.
title_sort neurocognitive dysfunction and brain fdg pet ct findings in hiv infected hemophilia patients and hiv infected non hemophilia patients
url https://doi.org/10.1371/journal.pone.0230292
work_keys_str_mv AT koubunimai neurocognitivedysfunctionandbrainfdgpetctfindingsinhivinfectedhemophiliapatientsandhivinfectednonhemophiliapatients
AT sotakimura neurocognitivedysfunctionandbrainfdgpetctfindingsinhivinfectedhemophiliapatientsandhivinfectednonhemophiliapatients
AT yokokiryu neurocognitivedysfunctionandbrainfdgpetctfindingsinhivinfectedhemophiliapatientsandhivinfectednonhemophiliapatients
AT akiwatanabe neurocognitivedysfunctionandbrainfdgpetctfindingsinhivinfectedhemophiliapatientsandhivinfectednonhemophiliapatients
AT eikinai neurocognitivedysfunctionandbrainfdgpetctfindingsinhivinfectedhemophiliapatientsandhivinfectednonhemophiliapatients
AT shinichioka neurocognitivedysfunctionandbrainfdgpetctfindingsinhivinfectedhemophiliapatientsandhivinfectednonhemophiliapatients
AT yoshimikikuchi neurocognitivedysfunctionandbrainfdgpetctfindingsinhivinfectedhemophiliapatientsandhivinfectednonhemophiliapatients
AT satoshikimura neurocognitivedysfunctionandbrainfdgpetctfindingsinhivinfectedhemophiliapatientsandhivinfectednonhemophiliapatients
AT mikikoogata neurocognitivedysfunctionandbrainfdgpetctfindingsinhivinfectedhemophiliapatientsandhivinfectednonhemophiliapatients
AT misaotakano neurocognitivedysfunctionandbrainfdgpetctfindingsinhivinfectedhemophiliapatientsandhivinfectednonhemophiliapatients
AT ryogominamimoto neurocognitivedysfunctionandbrainfdgpetctfindingsinhivinfectedhemophiliapatientsandhivinfectednonhemophiliapatients
AT masatoshihotta neurocognitivedysfunctionandbrainfdgpetctfindingsinhivinfectedhemophiliapatientsandhivinfectednonhemophiliapatients
AT kotayokoyama neurocognitivedysfunctionandbrainfdgpetctfindingsinhivinfectedhemophiliapatientsandhivinfectednonhemophiliapatients
AT tomoyukinoguchi neurocognitivedysfunctionandbrainfdgpetctfindingsinhivinfectedhemophiliapatientsandhivinfectednonhemophiliapatients
AT kensukekomatsu neurocognitivedysfunctionandbrainfdgpetctfindingsinhivinfectedhemophiliapatientsandhivinfectednonhemophiliapatients